1983;51:1941–3.Of 2114 patients who received postoperative radiotherapy for regional lymph node-positive breast cancer between 2009 and 2014, a total of 84 patients met the inclusion criteria for this study.
Even though the number of patients with a positive FNABx was not different between the patients with IMN < 1.0 cm and those with IMN ≥1.0 cm, half of our patients did not have pathologic confirmation of IMN metastasis.
Kim EJ, Kim SH, Kang BJ, Choi BG, Song BJ, Choi JJ. Hormonal therapy or anti-human epidermal growth factor receptor type 2 (HER2) treatment was administered according to the tumor subtypes. AJR Am J Roentgenol. About BMC Symptoms improved immediately after the distal revascularization and interval ligation procedure to the AV fistula. 2014;32:1230–6.Common terminology criteria for adverse eventsDepartment of Radiation Oncology, Ajou University School of Medicine, Suwon, South Koreahttps://doi.org/10.1186/s13014-020-1464-0Common Terminology Criteria for Adverse Events (CTCAE) U. S. Department of Health & Human Services. 2015;205:899–904.Cahoon AR, Smith BD, Yang WT. J Clin Oncol. A higher IMN dose was closely associated with better DFS. 2011;81:e689–95.Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era?
Patients were staged according to the 7th edition American Joint Committee on Cancer (AJCC) staging [After a median follow-up of 58 months (range, 12–111 months), IMN recurrence was observed in 2 patients (2.4%), and all IMN recurrences developed simultaneously with distant metastases.
The median age of patients was 41 years (range, 28–67 years). A total of 84 patients with cIMN+ were included in this analysis.
All rights reserved. Ten-year results Cancer. The 5-year locoregional recurrence-free survival, disease-free survival (DFS), and overall survival rates were 89.1, 72.0, and 81.2%, respectively. The surgeon chose the brachial artery for this AV fistula as the wrist cephalic vein was damaged as a result of previous venous cannulations. AJR Am J Roentgenol.
When the patient was reviewed in the clinic, she did have ongoing neuropathic symptoms with paraesthesia and hypoaesthesia.
Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. In patients with IMN size ≥1.0 cm, a high IMN radiation dose was significantly associated with improved DFS. There was 1 study each on liver and esophageal cancer. A Dosimetric comparison of breast radiotherapy techniques to treat Locoregional lymph nodes including the internal mammary chain.
Boost RT to the IMN was administered at the discretion of the attending physician, with a total dose of 6–16.5 Gy at 2–3.3 Gy per fraction. Of the remaining, 4 investigated IMN in colorectal cancer surgery, 2 in pancreatic surgery, and another 2 in patients undergoing surgery for gastric cancer. Internal mammary lymph nodes radiotherapy of breast cancer in the era of individualized medicine. You have entered an invalid code 2000;27:19–23.The IMN is situated in the parasternal region surrounded by the interpectoral muscle, fibrofatty tissue, and the internal mammary vessels [Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Your comment will be reviewed and published at the journal's discretion. Get published For patients with a large IMN, a higher IMN radiation dose might be needed for disease control.There were no cases of grade ≥ 3 toxicity. Radiotherapy for initial clinically positive internal mammary nodes in breast cancer. KY and HK contributed the design of this study, the analysis and interpretations of the data, and writing the manuscript.
Magn Reson Imaging.